event-trade登录编辑
PR Newswire BiotechnologyCodex · 实盘不做把握 3/10
北京时间·🕒 发布 00:48:00时区推断·⟳ 抓取 00:49:26·⚡ 决策 08-04 00:54:57 +5m31s·85.0 天前

Danone子公司METAbiotics在美国推出Akkermansia后生元体重管理补充剂

METAbiotics为Danone旗下Akkermansia Company的消费健康新品,原文只披露临床维护体重效果为安慰剂8倍,未披露销量、定价或营收目标。

📄 原文PR Newswire Biotechnology↗ 原文
While millions of people are achieving significant weight loss through GLP-1 medications, maintaining that progress ove…
不做 Danone(BN.FR)
消费健康子品牌新品发布未披露销售目标或利润贡献,相对Danone集团体量太小,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-08-03 · 扩散 low · price-in 风险 low ↗

消息传播链

  1. 2026-08-03 12:48 ET首发PRNewswire/METAbiotics The Akkermansia Company一手源原文 ↗
    品牌稿宣布两款METAbiotics产品在美国官网和Amazon上线,并披露8倍体重维持临床结果。

关键理由

  • METAbiotics为Danone旗下Akkermansia Company的消费健康新品,原文只披露临床维护体重效果为安慰剂8倍,未披露销量、定价或营收目标。

主要风险

  • 补充剂新品相对Danone集团收入体量过小,短期无法形成可量化业绩重定价。
工具调用 · 历史记录,结果未知(4 种)
  • search_processed_events · 结果未知
  • stock_quote · 结果未知
  • normalize_ticker · 结果未知
  • search_case_library · 结果未知

原文全文

展开原文 · 2,775 字
While millions of people are achieving significant weight loss through GLP-1 medications, maintaining that progress over time has become an increasingly important focus for consumers, healthcare professionals, and researchers alike.
"Most supplement brands license an ingredient. We discovered one," said Michael Oredsson, CEO of The Akkermansia Company. "Science isn't simply a proof point for METAbiotics, it's our foundation. Every product begins with original discovery and years of rigorous research, designed to help people support their health across every stage of life."
The scientists behind METAbiotics discovered, named, and advanced the science of Akkermansia muciniphila, one of the most researched next-generation microbes in the world. That work led to pasteurized Akkermansia muciniphila MucT®, a proven postbiotic that underpins the METAbiotics line.
"Your gut does far more than digest food," said Professor Willem M. de Vos, who led the research team that first isolated and characterized Akkermansia muciniphila and co-founded The Akkermansia Company. "Akkermansia MucT® strengthens the gut barrier, which has a measurable, positive effect on metabolic health. The clinical evidence supporting our patented strain in weight loss maintenance is an exciting step forward."
METAbiotics launches with two formulations designed to address distinct dimensions of metabolic wellness. The first, METAbiotics Weight Manager, is formulated to support healthy weight management and help maintain weight loss over time.
In a randomized clinical study, participants taking Akkermansia muciniphila MucT® were 8 times more likely to maintain their weight loss during the maintenance phase than those on a placebo.*
The second formulation, METAbiotics Metabolic Strength, is designed to support the body's natural metabolic adaptability, or its capacity to respond to everyday changes in diet, sleep, stress, aging, medications, and weight, while supporting healthy glucose metabolism, insulin function, gut barrier function, immune response, blood pressure, and overall metabolic health.
METAbiotics is available now in the U.S. at shopmetabiotics.com and on Amazon.
About METAbiotics The Akkermansia Company
METAbiotics is a consumer health brand from The Akkermansia Company, a Danone subsidiary dedicated to advancing the science of Akkermansia muciniphila. Built on decades of pioneering microbiome research, METAbiotics develops evidence-based postbiotic formulations that support metabolic adaptability, healthy weight management, and long-term metabolic health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SOURCE METAbiotics The Akkermansia Company

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。